Palomar Medical Tech (PMTI)

Palomar Medical Tech (PMTI) Stock Quote Information

Palomar Medical Technologies, Inc., together with its subsidiaries, designs, manufactures, markets, and sells lasers and other light-based products, and related disposable items and accessories for use in dermatology and cosmetic procedures. It provides a range of products for hair removal; body sculpting comprising laser-assisted liposuction; removal of vascular lesions, such as rosacea, spider veins, port wine stains, and hemangiomas; wrinkle reduction; removal of leg veins; removal of benign pigmented lesions, including age and sun spots, freckles, and melasma; tattoo removal; acne treatment; skin resurfacing; pseudofolliculitis barbae treatment; treatment of red pigmentation in hypertrophic and keloid scars; treatment of verrucae, skin tags, and seborrheic keratosis; skin tightening through soft tissue coagulation; scars, including acne scars, stretch marks, and warts; soft tissue coagulation; and various other skin treatments. Its proprietary technology products include EsteLux pulsed light system, Palomar MediLux pulsed light system, StarLux 300 and StarLux 500 pulsed light and laser systems, Aspire body sculpting system, Palomar EsteLux pulsed light system, and Palomar Q-YAG 5 system. Palomar Medical offers its products through a network of distributors in Europe, Japan, South America, Central America, the Far East, the Middle East, and Australia and New Zealand. The company was founded in 1987 and is headquartered in Burlington, Massachusetts.